Eric Benevich - Jun 1, 2018 Form 4/A - Amendment Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Commercial Officer
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Stock symbol
NBIX
Transactions as of
Jun 1, 2018
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/11/2023, 04:39 PM
Date Of Original Report
Jun 5, 2018
Next filing
May 11, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBIX Common Stock 17K Jun 1, 2018 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The initial Form 4 filed on 06/05/2018 inadvertently omitted 300 shares that the reporting person owned directly caused by the transposition of two digits.